These agents provide notable benefits in the treatment of uveitis as adjuncts to prevent significant ocular sequelae including: anterior and posterior synechiae, pupillary block, secondary angle closure, iris bombe, and pain/photophobia associated with ciliary spasm. The most significant difference among the commercially available medications is the onset and duration of action (Table 43.2).